Who owns the DIZAL trademark?

The DIZAL trademark is owned by Dizal (Jiangsu) Pharmaceutical Co., Ltd.

What is the serial number for DIZAL?

The USPTO serial number for DIZAL is 90221395.

What is the registration number for DIZAL?

DIZAL is registered under USPTO registration number 6890229.

DIZ

USPTO Trademark Record

REGISTERED

DIZAL

Q: What class is the DIZAL trademark registered in?

The DIZAL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

SN 90221395·Reg 6890229·Filed Sep 29, 2020

Owner Dizal (Jiangsu) Pharmaceutical Co., Ltd

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.

DIZAL (Serial No. 90221395), Registration No. 6890229, is a registered US trademark filed on Sep 29, 2020 by Dizal (Jiangsu) Pharmaceutical Co., Ltd. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

early section 8: November 01, 2028

Mark Intelligence

DIZAL (Reg. #6890229) is a registered US trademark that has been protecting its owner, Dizal (Jiangsu) Pharmaceutical Co., Ltd, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 035 (Advertising, business management & retail services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 29, 2020

SERIAL

90221395

REG#

6890229

REGISTERED

Nov 01, 2022

Owner

Applicant

Dizal (Jiangsu) Pharmaceutical Co., Ltd

Entity

Corporation

Address

Room 4015 Bldg. E(No.5) Huirong Business, Wuxi City, Jiangsu, N/A

Country

Attorney

NameCatherine M.C. Farrelly

Law firm

Catherine M.C. Farrelly Frankfurt Kurnit Klein & Selz PC

Docket

031221.0200

Address

28 Liberty Street, New York, NY 10005, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 29, 2020

Serial Number90221395

Registration No.6890229

Registration DateNov 01, 2022

Status DateNov 01, 2022

Published for OppositionJan 04, 2022

Mark TypeDesign with words

Attorney Docket031221.0200

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 27, 2017

First use in commerce: Nov 18, 2019

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: Oct 27, 2017

First use in commerce: Nov 18, 2019

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

47 events

REGISTERED-PRINCIPAL REGISTER

Nov 01, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 01, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 30, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ELECTRONIC RECORD REVIEW COMPLETE

Sep 28, 2022

ELECTRONIC RECORD REVIEW COMPLETE

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Sep 23, 2022

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 20, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 18, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Sep 16, 2022

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 14, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Aug 31, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Aug 31, 2022

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 01, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 04, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 04, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 15, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 24, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 22, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 22, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 22, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION E-MAILED

Oct 14, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 14, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Oct 14, 2021

NON-FINAL ACTION WRITTEN

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Oct 12, 2021

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Oct 05, 2021

WITHDRAWN FROM PUB - OG REVIEW QUERY

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 16, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 11, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Sep 10, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 10, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 03, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 03, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Sep 03, 2021

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Sep 03, 2021

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 03, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Sep 03, 2021

TEAS CHANGE OF OWNER ADDRESS RECEIVED

FINAL REFUSAL WRITTEN

Mar 12, 2021

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Mar 12, 2021

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 12, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 03, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 02, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 02, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION E-MAILED

Mar 01, 2021

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Mar 01, 2021

NON-FINAL ACTION WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 01, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 22, 2021

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 13, 2020

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 12, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 02, 2020

NEW APPLICATION ENTERED

DIZAL

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Dizal (Jiangsu) Pharmaceutical Co., Ltd

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Catherine M.C. Farrelly

Resources

Company